J. Petersen

717 total citations
38 papers, 483 citations indexed

About

J. Petersen is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, J. Petersen has authored 38 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 28 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in J. Petersen's work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (11 papers). J. Petersen is often cited by papers focused on Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (11 papers). J. Petersen collaborates with scholars based in Germany, United States and Netherlands. J. Petersen's co-authors include Maura Dandri, Markus Cornberg, Thomas Berg, Andreas Erhardt, Heiner Wedemeyer, Tassilo Volz, Marc Lütgehetmann, Ulrike Protzer, Wolfgang Jilg and Peter Buggisch and has published in prestigious journals such as Journal of Virology, Journal of Hepatology and Clinical & Experimental Immunology.

In The Last Decade

J. Petersen

34 papers receiving 473 citations

Peers

J. Petersen
Ayşın Zeytinoğlu Türkiye
Arturo Montineri Italy
Matsuo Deguchi Japan
Marika Arthur United States
Betsy Jett United States
Katharina Zoldan Germany
C. Sarrazin Germany
A. de Niet Netherlands
Karin Nielsen Netherlands
Lunzhi Yuan China
Ayşın Zeytinoğlu Türkiye
J. Petersen
Citations per year, relative to J. Petersen J. Petersen (= 1×) peers Ayşın Zeytinoğlu

Countries citing papers authored by J. Petersen

Since Specialization
Citations

This map shows the geographic impact of J. Petersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Petersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Petersen more than expected).

Fields of papers citing papers by J. Petersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Petersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Petersen. The network helps show where J. Petersen may publish in the future.

Co-authorship network of co-authors of J. Petersen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Petersen. A scholar is included among the top collaborators of J. Petersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Petersen. J. Petersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Xiaoqin, et al.. (2023). Assessment of Cardiac Performance by Global Longitudinal Strain after Aortic Valve Surgery in Severe Aortic Regurgitation. The Thoracic and Cardiovascular Surgeon. 71(S 01). S1–S72.
2.
Corti, Davide, Tassilo Volz, Katja Giersch, et al.. (2016). Prevention of Viral Spread, Viremia Reduction and HBsAg Clearance in Hepatitis B and D Coinfected Humanized Mice by a Human Neutralizing Monoclonal Antibody. Journal of Hepatology. 64(2). S510–S510. 1 indexed citations
3.
Kadayıfçı, Abdurrahman, George Papatheodoridis, MF Yuen, et al.. (2015). Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB). Hepatology International. 1 indexed citations
4.
5.
Buggisch, Peter, Christoph Sarrazin, Stefan Mauss, et al.. (2015). P0777 : Sofosbuvir-based treatment under real life conditions in Germany (The sofger trial). Journal of Hepatology. 62. S622–S622. 7 indexed citations
6.
Welzel, Tania M., J. Petersen, Michael Gschwantler, et al.. (2015). Daclatasvir plus Sofosbuvir with or without Ribavirin in patients infected with HCV genotype 3: Interim results of a multicenter compassionate use program in Europe. Zeitschrift für Gastroenterologie. 53(8). 4 indexed citations
7.
Petersen, J., R Heyne, JF Schlaak, et al.. (2014). O122 EFFECTIVENESS OF TENOFOVIR DF FOR CHRONIC HEPATITIS B IN FIELD PRACTICE – 3 YEAR FINAL RESULTS FROM THE PROSPECTIVE GERMAN MULTICENTER NON-INTERVENTIONAL STUDY. Journal of Hepatology. 60(1). S51–S51. 3 indexed citations
8.
9.
Petersen, J., R Heyne, JF Schlaak, et al.. (2012). 537 TENOFOVIR DF FOR CHRONIC HEPATITIS B PATIENTS IN FIELD PRACTICE - RESULTS FROM THE GEMINIS GERMAN MULTICENTER OBSERVATIONAL STUDY. Journal of Hepatology. 56. S212–S213. 5 indexed citations
10.
Lütgehetmann, Marc, Frank Meyer, Ansgar W. Lohse, et al.. (2010). Wissensstand, Präventionsverhalten und Therapie- adhärenz von Patienten mit chronischer Hepatitis B in einem großen tertiären Zentrum in Deutschland Knowledge about HBV, Prevention Behaviour and Treatment Adherence of Patients with Chronic Hepatitis B in a Large Referral Centre in Germany. 1 indexed citations
11.
Man, Robert A. de, Kerstin Stein, J. Petersen, et al.. (2008). 73 A MULTICENTER ANALYSIS OF ANTIVIRAL RESPONSE AFTER ONE YEAR OF TENOFOVIR MONO-THERAPY IN HBV-MONOINFECTED PATIENTS WITH PRIOR NUCLEOS(T)IDE ANALOG EXPERIENCE. Journal of Hepatology. 48. S32–S32. 18 indexed citations
12.
Dandri, Maura, et al.. (2008). 69 VIRION HALF-LIFE IN CHRONIC HEPATITIS B INFECTION IS STRONGLY CORRELATED WITH VIRAL LOAD. Journal of Hepatology. 48. S30–S31. 1 indexed citations
13.
Cornberg, Markus, Ulrike Protzer, Matthias Dollinger, et al.. (2008). The German guideline for the management of hepatitis B virus infection: short version*. Journal of Viral Hepatitis. 15(s1). 1–21. 20 indexed citations
14.
Cornberg, Markus, Ulrike Protzer, Matthias Dollinger, et al.. (2007). Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-(HBV-)Infektion: „Upgrade” der Leitlinie, AWMF-Register-Nr.: 021/011. Zeitschrift für Gastroenterologie. 45(6). 525–574. 29 indexed citations
15.
Cornberg, Markus, Ulrike Protzer, Matthias Dollinger, et al.. (2007). Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus (HBV) Infection: The German Guidelines for the Management of HBV Infection. Zeitschrift für Gastroenterologie. 45(12). 1281–1328. 45 indexed citations
16.
Dandri, Maura, Tassilo Volz, Marc Lütgehetmann, & J. Petersen. (2005). Animal models for the study of HBV replication and its variants. Journal of Clinical Virology. 34. S54–S62. 37 indexed citations
17.
Török, É, Joerg M. Pollok, Christian Vogel, et al.. (2001). Hepatic Tissue Engineering on 3-Dimensional Biodegradable Polymers within a Pulsatile Flow Bioreactor. Digestive Surgery. 18(3). 196–203. 19 indexed citations
18.
Török, É, Joerg M. Pollok, Peter Ma, et al.. (2001). Optimization of Hepatocyte Spheroid Formation for Hepatic Tissue Engineering on Three-Dimensional Biodegradable Polymer within a Flow Bioreactor prior to Implantation. Cells Tissues Organs. 169(1). 34–41. 45 indexed citations
19.
Petersen, J., et al.. (1997). Increase in the frequency of hepadnavirus DNA integrations by oxidative DNA damage and inhibition of DNA repair. Journal of Virology. 71(7). 5455–5463. 42 indexed citations
20.
Reinecker, Hans‐Christian, et al.. (1991). Proinflammatory cytokines in intestinal mucosa. Immunologic Research. 10(3-4). 247–248. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşın Zeytinoğlu Breakdown of academic impact, for papers by Arturo Montineri Breakdown of academic impact, for papers by Matsuo Deguchi Breakdown of academic impact, for papers by Marika Arthur Breakdown of academic impact, for papers by Betsy Jett Breakdown of academic impact, for papers by Katharina Zoldan Breakdown of academic impact, for papers by C. Sarrazin Breakdown of academic impact, for papers by A. de Niet Breakdown of academic impact, for papers by Karin Nielsen Breakdown of academic impact, for papers by Lunzhi Yuan
Rankless by CCL
2026